Send us a text

Editor-in-Chief Sue Yom co-hosts with Dr. Sarah Milgrom, Associate Professor in the Department of Radiation Oncology at the University of Colorado and Section Editor for Lymphoma, interviewing Dr. Brad Hoppe, Professor in the Department of Radiation Oncology and Medical Director of Particle Therapy from Mayo Clinic Jacksonville, who was last author on “The Role of Radiation Therapy in the Management of Grey Zone Lymphoma,” first author on “Comparison of Contemporary Radiotherapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331,” and submitting author of a striking art cover called “Set in Bloom” created by his young adult patient Katherine Beatty, a survivor of Gray Zone lymphoma, as well as Dr. Belinda Campbell, Associate Professor and Deputy Director of Radiation Oncology at Peter MacCallum Cancer Centre and first author of “Radiation therapy utilization for primary cutaneous T-cell lymphoma is lowest amongst patients living in the most geographically accessible areas; an Australian study.”

Send us a text

For ASTRO 2025, our Editor-in-Chief Dr. Sue Yom hosts Dr. Minesh Mehta, Chief, Deputy Director and John and Mary Lou Dasburg Endowed Chair in Radiation Oncology at Baptist Health Miami Cancer Institute and first author of the article “Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study”; Dr. Cliff Robinson, Professor and Chief of SBRT at Washington University in St. Louis, Thoracic Section Editor, and supervising author of Stereotactic Arrhythmia Radiotherapy (STAR) vs Repeat Catheter Ablation for High-Risk Refractory Ventricular Tachycardia: 3-Year Safety and Efficacy Outcomes; and Dr. Alexa Dang, Clinical Instructor in Radiation Oncology at BC Cancer in Vancouver and first author of Dosimetric Outcomes for Stereotactic Radiotherapy in Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Secondary Analysis of the ASPIRE-ILD Trial. 

Send us a text

Editor-in-Chief Dr. Sue Yom hosts Dr. Ben Corn, Professor of Oncology and Director of the Institute for the Study of Hope, Dignity & Wellbeing at Hebrew University School of Medicine in Jerusalem, and first author of our article published this month, ““Hope” Drives Quality of Life in Patients With Brain Metastases, But, the “Hope Center” Remains Elusive: An Analysis of NRG-CC003”; Dr. Vinai Gondi, Clinical Associate Professor and Service Line Director of Radiation Oncology in the Northwestern Medicine West Region, co-author on this paper and Principal Investigator of the parent clinical trial that enabled this study, NRG-CC003; and Dr. Tracy Balboni, Professor and Program Director of the Harvard Radiation Oncology Program, Director of Skeletal Radiation Oncology at Dana-Farber Cancer Center, Co-Director of the Initiative on Health, Spirituality, and Religion at Harvard, and the author of an accompanying editorial to this article, “Hope in Wisdom Past and for Future Clinical Trials.”

Send us a text

ASTRO has recently updated guidelines for post mastectomy radiotherapy (PMRT) to align practice with outcomes from multiple newly published studies for locally advanced breast cancer published over the past decade. This podcast, led by Melissa Pulfer Mitchell, MD, features lead authors of the new ASTRO PMRT guidelines Kathleen C. Horst, MD, and Rachel B. Jimenez, MD, and highlights the main questions answered by the new guidelines, as well as limitations of this expert consensus and lingering questions to be addressed. 

Send us a text

Dr. Sue Yom, Editor in Chief, co-hosts with Deputy Editor Dr. Alison Tree, in discussion/debate with Dr. John Floberg, Associate Professor and Director of Theranostics in the Department of Human Oncology at the University of Wisconsin and last author of “Severe Late Toxicities (Grade 3-5) with 13 Years of Follow-up after Hypofractionated Postprostatectomy Radiotherapy”; Dr. Paul Sargos, Head of the Department of Radiotherapy at the Institut Bergonié in Bordeaux, France and last author of an accompanying editorial, ”Hypofractionated radiotherapy for prostate cancer in the postoperative setting: is it capable of going the distance?”; and Dr. Ron Chen, Professor and Chair of Radiation Oncology at the University of Kansas, an Associate Editor at the journal, and a co-chair of NRG-GU003, who was corresponding author on a counterpoint editorial, “Long Term Outcomes in Hypofractionated Post-Prostatectomy Radiation: Cautionary Tale or Expected Findings?”

Send us a text

Editor-in-Chief Sue Yom hosts a discussion of lung cancer reirradiation with Dr. Charles Simone, Chief Medical Officer of the New York Proton Center and Full Member at Memorial Sloan Kettering and Dr. Kristen Higgins, Chief Clinical Officer for City of Hope Cancer Center Atlanta, first and co authors on a paper entitled “American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-Small Cell Lung Cancer Executive Summary.”

Send us a text

Editor in Chief Dr. Sue Yom hosts a discussion of reirradiation planning based on the Michigan model of the special medical physics consultation, as explained by guests Dr. Kelly Paradis, Associate Professor of Medical Physics in the Department of Radiation Oncology at the University of Michigan, and Dr. Martha Matuszak, the Laurie Snow Professor of Radiation Oncology and Associate Chair for Physics in the same group, who were first and co-last author on the article, “Reirradiation Special Medical Physics Consultations: Lessons Learned From Nearly 3000 Courses of Treatment.”​

Send us a text

Dr. Sue Yom, our Editor in Chief, hosts a discussion of workforce issues related to adaptive radiation therapy, with guests Dr. Lauren Henke, Associate Professor of Radiation Oncology at University Hospitals, Case Western Reserve University and Director of her department’s Residency and GI Programs, and last author of “Quality and Safety Considerations for Adaptive Radiation Therapy: An ASTRO White Paper” and Dr. Chirag Shah, Chair of the Allegheny Health Network Cancer Institute’s Division of Radiation Oncology and first author of an editorial from the ASTRO Workforce Committee entitled “Adaptive Radiation Therapy: Workforce Implications.”

Send us a text

ASTRO has recently released its first consensus guidelines on the treatment of anal cancer. This podcast, led by Michael Buckstein, MD PhD, features Dr. Mary Feng, lead author of the guidelines, and Dr. Chris Hallemeier as they discuss the nuances of the new guidelines, especially as it pertains to the more challenging aspects involving radiation for anal cancer. The podcast also explores some of the newer aspects of treatment for this rare disease and where we might be headed in the future.  

Send us a text

Editor in Chief Sue Yom hosts a discussion with Dr. Michelle Kim (CNS, University of Michigan), Dr. Michael Chuong (GI, Miami Cancer Institute), and Dr. Alison Tree (GU/editorials, The Royal Marsden NHS Foundation Trust), highlighting their top picks from their sections of the special issue.​